|Articles|December 1, 2002

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components
Volume 8
Issue 18 Suppl

The Role of Patient-Reported Outcomes in Evaluating the Quality of Oncology Care

Author(s)Cheryl R. Dennison, PhD, CRNP

Download PDF: The Role of Patient-Reported Outcomes in Evaluating the Quality of Oncology Care

Articles in this issue

over 23 years ago

Article

Participating Faculty

over 23 years ago

Article

Patient-Reported Outcomes and Managed Care Decisions: Quality of Life and Related Components

over 23 years ago

Article

An Introduction to Quality-of-Life Assessment in Oncology: The Value of Measuring Patient-Reported Outcomes

over 23 years ago

Article

Quality of Life and Symptom Measures in Oncology: An Overview

over 23 years ago

Article

Quality-of-Life Measurements: A Soft Outcome - Or is it?

over 23 years ago

Article

Continuing Medical Education Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

The Role of Patient-Reported Outcomes in Evaluating the Quality of Oncology Care

Articles in this issue

Related Content

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Trending on AJMC

What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO

GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Childhood Influenza Vaccine Rates Decreased From 2017 to 2023